Drugs / TAMP bioglass
TAMP bioglass
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03786302 | Dec 2016 → Aug 2018 | dental pulp disorder | Nourhan M.Aly | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAMP bioglass | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03786302 ↗ |
| Known as | Tailored amorphous multiporous bioglass | “Tailored amorphous multiporous bioglass (TAMP-BG) of 70% SiO2 / 30% CaO was prepared according to Wang et al. (2011, 2013) in the tissue engineering lab, Faculty of Dentistry,...” NCT03786302 ↗ |
| Known as | TAMP-BG | “Tailored amorphous multiporous bioglass (TAMP-BG) of 70% SiO2 / 30% CaO was prepared according to Wang et al. (2011, 2013) in the tissue engineering lab, Faculty of Dentistry,...” NCT03786302 ↗ |